CG
AGTC

Caprock Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Caprock Group’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-17,215
Closed -$119K – 478
2017
Q1 		$119K Buy
17,215
+6,165
+56% +$48.2K 0.03% 341
2016
Q4 		$103K Sell
11,050
-3,015
-21% -$27.2K 0.03% 329
2016
Q3 		$138K Buy
+14,065
New +$190K 0.03% 347

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caprock Group's AGTC Position: Q2 2017 in Review

Caprock Group sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2017, closing a stake of 17,215 shares — an estimated $119K sold.

Caprock Group first reported a position in AGTC in Q3 2016 and held it in 3 quarters. The position peaked at $138K in Q3 2016. 77 funds tracked by Wall St. Rank hold AGTC as of Q2 2017.

  • Caprock Group reported no remaining Applied Genetic Technologies Corporation position as of Q2 2017 after selling out during the quarter.
  • Caprock Group sold 17,215 Applied Genetic Technologies Corporation shares in Q2 2017, an estimated $119K.
  • Caprock Group first reported a position in Applied Genetic Technologies Corporation in Q3 2016 and held it in 3 quarters.
  • Caprock Group's Applied Genetic Technologies Corporation position peaked at $138K in Q3 2016.
  • 77 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2017.

Based on Caprock Group's 13F filing for Q2 2017, filed 27 Jul 2017.